Cipher Pharma Inc, along with partners Ranbaxy - a Sun Pharma firm - and Galephar Pharmaceutical Research, has entered into a patent litiga...

The drug is manufactured by Aurobindo Pharma at its Mahabub Nagar facility in Andhra Pradesh.

Aurobindo Pharma today reported a consolidated net profit of Rs 393.40 cr in the first quarter ended June 30, 2014 on good performance of U...

Shares of Aurobindo Pharma today climbed nearly 5% after the co completed acquisition of certain commercial operations of Actavis Plc in We...

The stock has rallied nearly 40 per cent so far in the year 2014.

Aurobindo Pharma today said it has completed acquisition of certain commercial operations of Actavis Plc in Western Europe.

Sanofi had submitted its application to seek US Food and Drug Administration's (USFDA's) approval for its generic version of the drug on Ja...

Aurobindo Pharma rallied as much as 6.8 per cent, after the generics drug maker signed a binding offer agreement to acquire Actavis.

Aurobindo expects to acquire personnel, commercial infrastructure, products, marketing authorisations and dossier licence rights in seven E...

Aurobindo Pharma is in talks with global pharma giant Actavis to buy their API units in Western Europe, sources familiar with the developme...

At 06:35 pm; Ranbaxy pared some of the morning gains and was trading 1.9% higher at Rs 411.05.

Absorica helped Ranbaxy shore up its sales in the US market in the September quarter. The drug commands 19% market share in the US.

Vivimed Labs today said it has acquired a manufacturing facility of Actavis Pharma Manufacturing Ltd for a total consideration of Rs 122 cr.

Glenmark Pharmaceuticals on Wednesday said its European arm, Medicamenta, has acquired seven pharmaceutical brands from Iceland-based gener...

Drug maker Glenmark Pharmaceuticals today said it has signed agreements with Iceland-based Actavis to acquire seven pharmaceutical brands i...

Actavis Group, the global generic pharma company, has announced the acquisition of the Active Pharmaceutical Ingredient (API).

Actavis Group, an international generic pharmaceuticals company has acquired the three-year-old manufacturing factory of Chennai-based Gran...